Peer Navigation for the Support of Metastatic Prostate Cancer Patients Undergoing Genetic Evaluation

This clinical trial evaluates whether having a trained peer navigator helps African American men with prostate cancer that has spread to other parts of the body (metastatic) understand and navigate the genetic testing process better than not having a peer navigator. Genetic testing for men with prostate cancer is very important for making treatment and management decisions. However, understanding the risks, benefits, and steps of genetic counseling and testing can be very challenging for patients. African American men are especially less likely to participant in genetic testing due to lack of awareness or understanding, cultural beliefs, finances, or mistrust of the healthcare system. A peer navigator, someone who helps a patient through the information and the process, may be helpful to some men. This study evaluates whether having a peer navigator throughout the genetic evaluation process helps patients understand and engage in the process more.

Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT05487846.

Trial PhaseNo phase specified

Trial Typehealth services research

Lead OrganizationThomas Jefferson University Hospital

Principal InvestigatorAmy Leader

• Primary ID21F.686
• Secondary IDsNCI-2022-06110
• ClinicalTrials.gov IDNCT05487846